Riskpilot← Back to searchSign inGet full accessPharm match AB
ABActiveOrg 5591279012Musseronvägen 21Temporary employment agency activities and other human resource provisions · NACE 7820Est. 20175-9 employees
Revenue 2024
SEK 37M
-58% vs 2023
EBITDA margin
3.5%
-62% vs 2023
Equity ratio
17.6%
Financial strength
Net profit 2024
SEK 644K
+119% vs 2023
| Revenue | SEK 37M | -58% |
| EBITDA | SEK 1,3M | -62% |
| Net profit | SEK 644K | +119% |
| Total assets | SEK 29,2M | -35% |
| Equity | SEK 5,1M | -7% |
| Employees | — | — |
Legal name
Pharm match AB
Org number
5591279012
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
4 oktober 2017
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet uthyrning av personal samt headhunting till andra bolag inom läkemedelsindustrin samt äga och förvalta fastigheter och värdepapper.
Address
Musseronvägen 21
Email
luay_katan@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 2 092 | 8 135 | 6 132 | 11 306 | 28 764 | 87 228 | 36 955 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 1 298 | 3 067 | 1 822 | 2 432 | 5 538 | 3 424 | 1 290 |
| Depreciation & amort. | −53 | −139 | −86 | −141 | −104 | −130 | −152 |
| EBIT | 1 245 | 2 928 | 1 736 | 2 291 | 5 434 | 3 294 | 1 138 |
| Net financials | — | — | −1 | −44 | 158 | −679 | −545 |
| Profit before tax | 1 245 | 2 928 | 1 296 | 1 658 | 4 151 | 3 563 | 330 |
| Tax | −277 | −643 | −284 | −364 | −891 | −6 926 | 314 |
| Net profit | 968 | 2 285 | 1 012 | 1 294 | 3 260 | −3 363 | 644 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 897 | 5 959 | 6 511 | 12 671 | 22 931 | 44 630 | 29 193 |
| Equity | 1 018 | 3 303 | 4 315 | 5 609 | 8 869 | 5 505 | 5 146 |
| Long-term debt | 0 | 0 | 0 | 2 884 | 4 392 | 9 213 | 9 034 |
| Short-term debt | 879 | 2 656 | 1 756 | 3 148 | 7 200 | 28 389 | 13 226 |
| Total debt | 879 | 2 656 | 1 756 | 6 032 | 11 592 | 37 602 | 22 260 |
EBITDA margin
3.5%
This company
15.8%
Market median
-78% vs market
20182024
Equity ratio
17.6%
This company
38.2%
Market median
-54% vs market
20182024
Return on equity
12.5%
This company
18.4%
Market median
+32% vs market
20182024
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
20182024
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20182024
Debt / equity
4.67×
This company
0.62×
Market median
-653% vs market
20182024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-10-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HA Audit | Audit | 2024 | — | — |
EG Audit | Audit | 2022 | — | — |
GI | Audit | 2022 | — | — |
PG | Audit | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharm match AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Halit Akan | Audit | 0 companies |
| Erik Gunnar Ågerup | Audit | 0 companies |
| Ghassan Imad Suleiman | Audit | 0 companies |
| Per Göran Ivan Andersson | Audit | 0 companies |
| Sammy Al-Obaidi | Deputy Board Member | 0 companies |
| Luay Walid Kheder Katan | Board of Directors | 0 companies |
| Qattan Akram Khudhur Qattan | Deputy Board Member | 0 companies |
| Kosai Walid Kheder Katan | Deputy Board Member | 0 companies |